ArticleAntimicrobial stewardship & healthcare epidemiology : ASHE2026
Bridging knowledge and practice: Antimicrobial Stewardship by community pharmacists in New Zealand.
Article in Antimicrobial stewardship & healthcare epidemiology : ASHE, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study assessed knowledge, perceptions, practices, and barriers regarding Antimicrobial Stewardship (AMS) among community pharmacists in New Zealand. Design: A cross-sectional study using a self-administered online questionnaire distributed nationwide to community pharmacists. Methods: A structured questionnaire was distributed via email to 3,226 pharmacists between January and March 2025, assessing demographics, knowledge of antimicrobial resistance (AMR) and antibiotic use, perceptions of AMS, current practices, and barriers. A total of 325 responses underwent quantitative analysis using Mann-Whitney U and Kruskal-Wallis tests ( Results: Most respondents (82.8%) perceived community pharmacists as holding a significant role in AMS. While demonstrating strong AMR knowledge (median score 5/7) and positive attitudes (82.7% agreed AMS should be implemented in community pharmacies), practices varied considerably. Patient education on proper antibiotic use was consistent (81.6% always/often), but education on resistance issues was less frequent (40.6% occasionally). Only 27.7% always/often reviewed prescriptions against local guidelines. Primary barriers were lack of time (66.5%), lack of support from higher authorities (64.3%), inadequate staff numbers (61.5%), and limited access to patient records (54.2%). Younger, less experienced pharmacists demonstrated higher knowledge scores ( Conclusions: Community pharmacists in New Zealand are well-positioned for effective AMS but are hindered by structural and system-level barriers rather than knowledge deficits. Recommendations include developing AMS guidelines tailored to community pharmacists, implementing joint training with prescribers, and establishing annual e-learning refresher modules.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.